Entering the US pharmaceutical market requires strict compliance with US FDA drug registration and listing rules. Before a drug can be legally manufactured, processed, or distributed in the United States, the facility and the product must appear in the official FDA systems. This is where FDA drug registration and listing search becomes a critical compliance step for manufacturers, exporters, and regulatory teams.
Understanding FDA Drug Registration
Drug registration refers to establishment registration, a mandatory annual requirement under the US Federal Food, Drug, and Cosmetic Act. Any domestic or foreign facility involved in drug manufacturing, repackaging, relabeling, or testing must register with the U.S. Food and Drug Administration. Upon successful registration, the FDA assigns a Facility Establishment Identifier (FEI) number, which uniquely identifies the manufacturing site.
Foreign drug manufacturers must also appoint a US FDA U.S. Agent to act as the official point of contact with the agency. Without proper establishment registration, drugs cannot be legally imported or marketed in the United States.
What Is FDA Drug Listing?
FDA drug listing is product-specific. After establishment registration, companies must submit detailed drug listing information, including dosage form, route of administration, strength, and National Drug Code (NDC). Drug listings must be updated whenever changes occur and reconfirmed annually. An active listing confirms that the FDA has the required data for market surveillance, inspections, and recalls.
How FDA Drug Registration and Listing Search Works
The FDA provides public databases that allow users to perform FDA drug registration and listing searches. These tools help verify whether a drug manufacturer is registered and whether a specific drug product is listed with the agency. Importers, distributors, and regulatory partners often rely on these searches to confirm compliance before engaging in business or shipping products to the US.
It is important to note that FDA registration and listing do not mean product approval. Instead, they confirm regulatory disclosure and legal presence within FDA systems.
Why Accurate Registration and Listing Matter
Errors, expired registrations, or missing listings can lead to shipment holds, import alerts, warning letters, or refusal of admission at US ports. Maintaining accurate and up-to-date FDA records is essential for uninterrupted US market access.
This is where professional regulatory support adds value. XPRO America, a US FDA Consultancy, assists global pharmaceutical companies with end-to-end FDA drug establishment registration, product listing, U.S. Agent services, and ongoing compliance management. Their expertise helps reduce regulatory risk and ensures filings are completed correctly and on time.
For companies seeking reliable assistance with FDA drug registration and listing search or compliance strategy, reaching out to the XPRO America regulatory team at support@xproamerica.com can simplify the entire process and support long-term success in the US pharmaceutical market.
Leave a Reply